Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Miyazawa, Yoshiyuki; Sekine, Yoshitaka; Syuto, Takahiro; Nomura, Masashi; Koike, Hidekazu; Matsui, Hiroshi; Shibata, Yasuhiro; Ito, Kazuto; Suzuki, Kazuhiro, 2017, ANTICANCER RESEARCH
YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike,Takashi Nitta,Yoshitaka Sekine,Seiji Arai,Yosuke Furuya,Masashi Nomura,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Tetsunari Oyama,Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
YM155 reverses rapamycin resistance in renal cancer by decreasing survivin, Hidekazu Koike,Takashi Nitta,Yoshitaka Sekine,Seiji Arai,Yosuke Furuya,Masashi Nomura,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Tetsunari Oyama,Kazuhiro Suzuki, Oct. 2014, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 140, 10, 1705, 1713
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab, Yoshiyuki Miyazawa,Yoshitaka Sekine,Takahiro Syuto,Masashi Nomura,Hidekazu Koike,Hiroshi Matsui,Yasuhiro Shibata,Kazuto Ito,Kazuhiro Suzuki, Jul. 2017, ANTICANCER RESEARCH, 37, 7, 3667, 3671